BioPorto A/S (CPH:BIOPOR)
1.205
+0.035 (2.99%)
Jul 28, 2026, 4:59 PM CET
BioPorto Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 40.29 | 36.24 | 30.96 | 28.97 | 24.25 | |
Revenue Growth | 11.16% | 17.07% | 6.87% | 19.44% | 4.52% |
Cost of Revenue | 9.9 | 11.71 | 10.78 | 9.93 | 9.21 |
Gross Profit | 30.39 | 24.53 | 20.18 | 19.04 | 15.04 |
Selling, General & Admin | 66.02 | 66.45 | 54.9 | 63.05 | 50.04 |
Research & Development | 50.47 | 33.53 | 25.45 | 34.94 | 30.26 |
Other Operating Expenses | - | - | 1.01 | 2.58 | - |
Total Operating Expenses | 116.49 | 99.98 | 81.35 | 100.57 | 80.3 |
Operating Income | -86.09 | -75.45 | -61.17 | -81.53 | -65.26 |
Interest Income | 0.51 | 2.54 | 1.04 | 1.19 | 2.46 |
Interest Expense | -2.05 | -0.83 | -1.07 | -1.21 | -1.05 |
Total Non-Operating Income (Expense) | -1.54 | 1.71 | -0.04 | -0.02 | 1.42 |
Pretax Income | -87.64 | -73.74 | -61.21 | -81.55 | -63.84 |
Provision for Income Taxes | -5.52 | -5.5 | -4.88 | -5.62 | -6.73 |
Net Income | -82.12 | -68.24 | -56.33 | -75.92 | -57.11 |
Net Income to Common | -82.12 | -68.24 | -56.33 | -75.92 | -57.11 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 538 | 406 | 358 | 319 | 267 |
Shares Outstanding (Diluted) | 538 | 406 | 358 | 319 | 267 |
Shares Change | 32.47% | 13.18% | 12.54% | 19.11% | 30.21% |
EPS (Basic) | -0.15 | -0.17 | -0.16 | -0.24 | -0.21 |
EPS (Diluted) | -0.15 | -0.17 | -0.16 | -0.24 | -0.21 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -77.07 | -83.93 | -55.5 | -52.89 | -64.71 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.14 | -0.21 | -0.15 | -0.17 | -0.24 |
Gross Margin | 75.44% | 67.68% | 65.19% | 65.73% | 62.01% |
Operating Margin | -213.70% | -208.18% | -197.60% | -281.43% | -269.05% |
Profit Margin | -203.83% | -188.29% | -181.95% | -262.08% | -235.48% |
FCF Margin | -191.29% | -231.58% | -179.26% | -182.58% | -266.79% |
EBITDA | -83.59 | -73.07 | -58.49 | -77.56 | -60.93 |
EBITDA Margin | -207.48% | -201.61% | -188.95% | -267.74% | -251.20% |
EBIT | -86.09 | -75.45 | -61.17 | -81.53 | -65.26 |
EBIT Margin | -213.70% | -208.18% | -197.60% | -281.43% | -269.05% |
Effective Tax Rate | 6.30% | 7.46% | 7.97% | 6.90% | 10.54% |